Infectious Diseases Consultant Advisory Board Member Michael Reid, MD, discusses his work in helping establish a contact tracing and case investigation infrastructure in San Francisco, California, to help mitigate the COVID-19 pandemic.
A new study examined the association between states with and without stay-at-home orders and the epidemic doubling time for COVID-19. Lead researcher Mark Lurie, PhD, MPH, answered our questions about the findings.
New findings published in JAMA Internal Medicine have added to increasing evidence of the disproportionate impact of COVID-19 based on race/ethnicity.
New findings published in The Lancet indicate that a SARS-CoV-2 vaccine candidate that was developed in the United Kingdom showed promise in a phase 1/2 trial, supporting its evaluation in an ongoing phase 3 trial.
This vaccine candidate appeared to induce immune responses among all participants included in the trial, supporting further development of the vaccine, according to phase 1 trial findings published in the New England Journal of Medicine.
Timothy Farrell, MD, AGSF, on Resource Allocation and Age-Related Considerations During the Pandemic
In May 2020, the American Geriatrics Society issued a position statement on strategies for resource allocation and age-related considerations during the COVID-19 pandemic. Corresponding author Timothy Farrell, MD, AGSF, answers our questions about the position statement.
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized patients with severe COVID-19 as the pandemic progresses.
Intravenous remdesivir appears to reduce time to recovery compared with placebo among certain patients with COVID-19, according to new, preliminary data published in the New England Journal of Medicine.
Patients with mild to moderate COVID-19 who received this triple antiviral therapy early had a shortened duration of SARS-CoV-2 viral shedding and hospital stay compared with controls.
Rates of childhood vaccinations have decreased since the start of the COVID-19 pandemic, according to an analysis from the Centers for Disease Control and Prevention.